Article

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis

2025-10-27

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> .Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) reflect axonal damage and astrocytic injury. Their clinical role in longitudinal real-world monitoring after immune reconstitution therapy (IRT) in multiple sclerosis (MS) remains insufficiently defined. We evaluated longitudinal sNfL and sGFAP in people with multiple sclerosis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3933bb21-d889-5983-ac5e-bf721952c70f
DOI: 10.21203/rs.3.rs-7736188/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisDOI 10.21203/rs.3.rs-7736188/v1Read

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisSemantic proximity Read

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple SclerosisSemantic proximity Read

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read

Biomarkers of Progression Independent of Relapse Activity—Can We Actually Measure It Yet?Semantic proximity Read

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosisSemantic proximity Read

A Predictive Autoantibody Signature in Multiple SclerosisSemantic proximity Read

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisSemantic proximity Read

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.Semantic proximity Read

Increased Disability Progression in rs10191329AA Carriers with Multiple Sclerosis Is Preceded by Neurofilament Light Chain Elevations.Semantic proximity Read

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read